Biotech Stocks
Recent market-moving SEC filings and news across biotech companies, ranked by Wiseek's 1–10 importance score.
How Wiseek curates this list
Every item here is a high-importance (score ≥ 7) SEC filing or licensed news event for a biotech company, sourced from SEC EDGAR and licensed news wires and ranked by Wiseek's 1–10 importance score. The underlying source is linked from each article. See our methodology and editorial policy.
Related Healthcare industries
Medical Device StocksPharmaceutical StocksHealth Tech StocksDiagnostics & Research StocksMedical Instrument StocksHealthcare Facility Stocks
See the full Healthcare sector feed.
Averill Funds Sell $80.4M Veradermics Stock and Exercise 300K Warrants
Montanova Capital Sells $80.4M of Veradermics Stock at $107.25
GridAI Technologies' Q2 10-Q Discloses $10.1M Goodwill Impairment, Material Weakness, and Going Concern Doubt
Nasdaq Moves to Delist Adial Pharmaceuticals Over Equity Shortfall
Moleculin Upsizes ATM to $19.7M, Sells $1.9M in Shares
Nasdaq Extends Bid Price Compliance Deadline to February 2027
Nasdaq Sends Delisting Notice to Estrella Immunopharma Over Sub-$1.00 Bid Price
Bering Partners Reports 9.99% Stake After Warrant Issuance
Tempest Registers 8.9M Shares for Lincoln Park Equity Line — Up to $50M in Dilutive Financing
Nuvectis Files $200M Shelf and $75M ATM, Replacing Prior Programs
BioCardia Receives Nasdaq Minimum Bid Price Deficiency Notice
Alzamend Neuro Registers 98.4M Shares for Ault Lending Resale — Potential 20x Dilution
Nasdaq Moves to Delist Silexion Therapeutics
Oruka Upsizes ATM to $500M and Files $1B Universal Shelf
Citius Pharma Gets Nasdaq Extension to Feb 8, 2027 to Regain $1 Bid Compliance
Aptevo Seeks Stockholder Approval for 5.58M Warrant Shares and 180K New Equity Plan Shares
Aptevo Registers 6.4M Resale Shares from $4.5M Warrant Financing
VivoSim Labs Receives New Nasdaq Delisting Notice for Bid Price Deficiency
VivoSim Seeks Approval for Reverse Split, Equity Plan Increase, and Warrant Share Issuance
Forte Biosciences Discloses Nine Shareholder Demand Letters and $43M Advisor Fee in Tender Offer Amendment
Loewenbaum Group Cuts Stake to 24.99% After Removing Three Members
Jaguar Health Registers 40.9M Shares for C/M Capital Resale Under $40M Equity Line
Activist Investor Demands Governance Reset and Cash Preservation at Capricor
Arbutus Launches $230M Dutch Auction Tender, Shares Hit 52-Week High
CDT Equity Files Sarborg Financials: $30.9M Warrant Dilution and Sarborg's Own Going Concern Warning
CDT Equity details highly dilutive 20% stake in AI firm Sarborg, valued at $115M
Werewolf Files Full Merger Agreement with Ambros: $500M Reverse Merger, $150M PIPE, and CVR for Legacy Assets
Werewolf Therapeutics to Merge with Ambros Therapeutics in $500M All-Stock Deal with $150M PIPE
Werewolf Shares Double as Reverse Merger Details Emerge: $47.5M Implied Value, 6.8% Stake
Gossamer Bio Secures Up to $250M Structured Private Placement to Fund Seralutinib Through FDA Approval
Werewolf Therapeutics to Merge with Ambros, Raises $150M in Oversubscribed Placement
Milestone Starts Pivotal Phase 3 Trial for Etripamil in AFib-RVR
Gossamer Bio Secures Up to $250M to Fund Seralutinib Through FDA Approval
Arbutus Launches $230M Dutch Auction Tender Offer at $5.00–$5.75
Theravance Biopharma Sets September 18 Vote on $17/Share Zymeworks Merger
5AM Ventures Sells Additional 75,840 Shares, Total Disposition Reaches $140K
Amylyx Formalizes $500M Upsized Offering: $471.7M Net Proceeds, Closing August 21
Amylyx Prices Upsized $500M Offering at $35.50 After Avexitide Win
Bio-Techne Sets September 23 Shareholder Vote on $73/Share Merck KGaA Merger
Edesa Biotech Prices $25M Public Offering at $5.50 with Warrants, 17% Discount